416 related articles for article (PubMed ID: 6408173)
1. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
Nadler LM; Anderson KC; Marti G; Bates M; Park E; Daley JF; Schlossman SF
J Immunol; 1983 Jul; 131(1):244-50. PubMed ID: 6408173
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a human B cell-specific antigen (B2) distinct from B1.
Nadler LM; Stashenko P; Hardy R; van Agthoven A; Terhorst C; Schlossman SF
J Immunol; 1981 May; 126(5):1941-7. PubMed ID: 6163824
[TBL] [Abstract][Full Text] [Related]
3. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
[TBL] [Abstract][Full Text] [Related]
4. B5, a new B cell-restricted activation antigen.
Freedman AS; Boyd AW; Anderson KC; Fisher DC; Schlossman SF; Nadler LM
J Immunol; 1985 Apr; 134(4):2228-35. PubMed ID: 2579134
[TBL] [Abstract][Full Text] [Related]
5. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
7. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
Mathé G
Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
[TBL] [Abstract][Full Text] [Related]
8. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
[TBL] [Abstract][Full Text] [Related]
9. A novel human B-lymphocyte antigen shared with lymphoid dendritic cells: characterization by monoclonal antibody.
Ishii Y; Takami T; Kokai Y; Yuasa H; Fujimoto J; Takei T; Kikuchi K
Clin Exp Immunol; 1985 Sep; 61(3):624-32. PubMed ID: 3907905
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells.
Anderson KC; Bates MP; Slaughenhoupt B; Schlossman SF; Nadler LM
J Immunol; 1984 Jun; 132(6):3172-9. PubMed ID: 6427334
[TBL] [Abstract][Full Text] [Related]
11. B7, a B-cell-restricted antigen that identifies preactivated B cells.
Freedman AS; Freeman G; Horowitz JC; Daley J; Nadler LM
J Immunol; 1987 Nov; 139(10):3260-7. PubMed ID: 3500211
[TBL] [Abstract][Full Text] [Related]
12. B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation.
Storkus WJ; Dawson JR
J Immunol; 1986 Mar; 136(5):1542-7. PubMed ID: 3081629
[TBL] [Abstract][Full Text] [Related]
13. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus.
Thorley-Lawson DA; Nadler LM; Bhan AK; Schooley RT
J Immunol; 1985 May; 134(5):3007-12. PubMed ID: 2984280
[TBL] [Abstract][Full Text] [Related]
14. Antigens on human plasma cells identified by monoclonal antibodies.
Anderson KC; Park EK; Bates MP; Leonard RC; Hardy R; Schlossman SF; Nadler LM
J Immunol; 1983 Mar; 130(3):1132-8. PubMed ID: 6401780
[TBL] [Abstract][Full Text] [Related]
15. Induction of B-lymphocyte antigens on the chronic myeloid leukemic cell line K562 using sodium butyrate.
Fraser JK; Berridge MV
Exp Hematol; 1987 May; 15(4):406-13. PubMed ID: 2952519
[TBL] [Abstract][Full Text] [Related]
16. Malignant human B cells express two populations of p24 surface antigens.
Pesando JM; Hoffman P; Conrad T
J Immunol; 1986 Apr; 136(7):2709-14. PubMed ID: 3485154
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
[TBL] [Abstract][Full Text] [Related]
18. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
19. Phenotype and ontogeny of cells carrying a tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma.
Aida Y; Okada K; Amanuma H
Cancer Res; 1993 Jan; 53(2):429-37. PubMed ID: 8380256
[TBL] [Abstract][Full Text] [Related]
20. The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA).
Miller RA; Gralow J
J Immunol; 1984 Dec; 133(6):3408-14. PubMed ID: 6436381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
